InsidersTradesSigma
Follow the 인투셀 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 인투셀 has published 12 insider filings. The latest transaction was reported on 2 February 2026 (Purchase). Among the most active insiders: 서영석. Every trade is openly available.
12
Insider Decl.
n/a
Thresholds
n/a
11 ops.
Buy Volume
n/a
1 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 2 February 2026
Declarations12 total
861,587 sharesKRXDART:20250529000443
12 of 12 declarations
关于 인투셀
인투셀 是一家在XKRX市场上市的医疗保健和制药公司。它专注于开发创新的疾病治疗解决方案。